rs892202419

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_080732.4(EGLN2):​c.9C>A​(p.Ser3Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000691 in 1,447,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S3G) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

EGLN2
NM_080732.4 missense

Scores

2
3
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.514
Variant links:
Genes affected
EGLN2 (HGNC:14660): (egl-9 family hypoxia inducible factor 2) The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene. [provided by RefSeq, Feb 2011]
RAB4B-EGLN2 (HGNC:44465): (RAB4B-EGLN2 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RAB4B (RAB4B, member RAS oncogene family) and EGLN2 (egl nine homolog 2) genes on chromosome 19. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13495964).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EGLN2NM_080732.4 linkc.9C>A p.Ser3Arg missense_variant Exon 2 of 6 ENST00000303961.9 NP_542770.2 Q96KS0-1A0A024R0R2
EGLN2NM_053046.4 linkc.9C>A p.Ser3Arg missense_variant Exon 2 of 6 NP_444274.1 Q96KS0-1A0A024R0R2
RAB4B-EGLN2NR_037791.1 linkn.1057C>A non_coding_transcript_exon_variant Exon 8 of 12

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EGLN2ENST00000303961.9 linkc.9C>A p.Ser3Arg missense_variant Exon 2 of 6 1 NM_080732.4 ENSP00000307080.3 Q96KS0-1
RAB4B-EGLN2ENST00000594136.2 linkn.*258C>A non_coding_transcript_exon_variant Exon 8 of 12 2 ENSP00000469872.1
RAB4B-EGLN2ENST00000594136.2 linkn.*258C>A 3_prime_UTR_variant Exon 8 of 12 2 ENSP00000469872.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.91e-7
AC:
1
AN:
1447092
Hom.:
0
Cov.:
32
AF XY:
0.00000139
AC XY:
1
AN XY:
718378
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000118
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.094
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
.;T;T;T;T;.;.;.;.;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.097
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.77
T;.;T;.;T;T;T;T;T;T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.13
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
.;N;.;N;N;.;.;.;.;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.11
.;N;.;N;.;.;.;.;.;.
REVEL
Benign
0.15
Sift
Pathogenic
0.0
.;D;.;D;.;.;.;.;.;.
Sift4G
Pathogenic
0.0
D;T;D;T;T;D;D;D;D;D
Polyphen
0.11
.;B;.;B;B;.;.;.;.;.
Vest4
0.20, 0.21, 0.17
MutPred
0.17
Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);Loss of phosphorylation at S3 (P = 0.0185);
MVP
0.55
MPC
0.63
ClinPred
0.60
D
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.18
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-41306486; API